Clinical Trial Update: Survey on QUality of Life In myeloDisplasia (SQUID)

View source ↗

Summary

This entry reports the completion of a Janssen-sponsored clinical trial (SQUID) assessing quality of life in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Myelodysplastic Syndromes | Status: COMPLETED